These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16847892)

  • 1. RNAi and microRNAs: from animal models to disease therapy.
    Fjose A; Drivenes O
    Birth Defects Res C Embryo Today; 2006 Jun; 78(2):150-71. PubMed ID: 16847892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospects of RNAi and microRNA-based therapies for hepatitis C.
    Pan Q; Tilanus HW; Janssen HL; van der Laan LJ
    Expert Opin Biol Ther; 2009 Jun; 9(6):713-24. PubMed ID: 19456206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commercial potential of RNAi.
    Jain KK
    Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference as potential therapy for neurodegenerative disease: applications to inclusion-body myositis?
    Paulson H
    Neurology; 2006 Jan; 66(2 Suppl 1):S114-7. PubMed ID: 16432138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological potential of RNAi--focus on miRNA.
    Pfeifer A; Lehmann H
    Pharmacol Ther; 2010 Jun; 126(3):217-27. PubMed ID: 20388525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNA interference: a tool for querying nervous system function and an emerging therapy.
    Davidson BL; Boudreau RL
    Neuron; 2007 Mar; 53(6):781-8. PubMed ID: 17359914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology Insight: small, noncoding RNA molecules as tools to study and treat endocrine diseases.
    Kolfschoten IG; Regazzi R
    Nat Clin Pract Endocrinol Metab; 2007 Dec; 3(12):827-34. PubMed ID: 18026161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of RNA interference in cancer therapy.
    Phalon C; Rao DD; Nemunaitis J
    Expert Rev Mol Med; 2010 Aug; 12():e26. PubMed ID: 20716384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral vector-mediated RNA interference.
    Couto LB; High KA
    Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring microRNA functions in zebrafish.
    Fjose A; Zhao XF
    N Biotechnol; 2010 Jul; 27(3):250-5. PubMed ID: 20219709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects of RNA interference therapy for cancer.
    Pai SI; Lin YY; Macaes B; Meneshian A; Hung CF; Wu TC
    Gene Ther; 2006 Mar; 13(6):464-77. PubMed ID: 16341059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference based gene therapy for neurological disease.
    Jagannath A; Wood M
    Brief Funct Genomic Proteomic; 2007 Mar; 6(1):40-9. PubMed ID: 17478451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-transcriptional gene silencing by RNA interference in non-mammalian vertebrate systems: where do we stand?
    Sifuentes-Romero I; Milton SL; GarcĂ­a-Gasca A
    Mutat Res; 2011; 728(3):158-71. PubMed ID: 21930237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
    DeVincenzo JP
    Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of microRNAs for pathogenesis and treatment of hepatitis C virus infection.
    Pfeffer S; Baumert TF
    Gastroenterol Clin Biol; 2010 Sep; 34(8-9):431-5. PubMed ID: 20537478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in common diseases and potential therapeutic applications.
    Tsai LM; Yu D
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):102-7. PubMed ID: 19671070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs: biogenesis, function and applications.
    Chua JH; Armugam A; Jeyaseelan K
    Curr Opin Mol Ther; 2009 Apr; 11(2):189-99. PubMed ID: 19330724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Not miR-ly small RNAs: big potential for microRNAs in therapy.
    Love TM; Moffett HF; Novina CD
    J Allergy Clin Immunol; 2008 Feb; 121(2):309-19. PubMed ID: 18269923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A brief introduction to RNAi and microRNAs in stem cells.
    Murashov AK
    Methods Mol Biol; 2010; 650():15-25. PubMed ID: 20686940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.